Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Rare diseases

Anna Alassaad: no licensed photograph is held, so the sector leader plate is shown instead.
Sector leader

Anna Alassaad

chief strategist at the TLV, the Swedish Dental and Pharmaceutical Benefits Agency

Press citations per month · linked articles
1
0
0
0
0
0
June 2026July 2026Aug 2026Sept 2026Oct 2026Nov 2026to date
1

press citation on 1 topic since 2 Jun 2026 · last quoted 2 Jun 2026

02  Quoted on · 1 of 29 topics

Open the topic

Anna Alassaad: key facts

Kind of voice
Sector leader
Role
chief strategist at the TLV, the Swedish Dental and Pharmaceutical Benefits Agency
Quoted on
Rare diseases
Tracked press citations
1
Most recently quoted
2 Jun 2026

04  The signal · where Anna Alassaad sits on rare diseases

Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
  2. 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
  3. 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
  4. 25=Christian Gilissen, PhDAcademicprofessor of genome bioinformatics at Radboud University Medical Center1
  5. 25=Lisenka Vissers, PhDAcademicprofessor of translational genomics at Radboud University Medical Center1
  6. 25=Anna AlassaadSector leaderchief strategist at the TLV, the Swedish Dental and Pharmaceutical Benefits Agency1
  7. 25=Katarina AntonovSector leaderhead of analysis at LIF, the Swedish Association of Research-Based Pharmaceutical Companies1
  8. 25=Oskar AhlbergSector leadervice-president of Rare Disease Sweden1

Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →

05  On the record · press

What Anna Alassaad has said

By outlet · linked articles
  • euractiv.com1

Where Anna Alassaad has been quoted

  1. 01Swedish rare disease patients endure longer wait for new medicineseuractiv.com · 2 Jun 2026

Verbatim

“This could both be dependent on how fast manufacturers apply for a reimbursement and the agency's processing time of an application for reimbursement.”
chief strategist at the TLV, the Swedish Dental and Pharmaceutical Benefits Agency · Rare diseases · euractiv.com · 2 Jun 2026 · Read the article

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.